Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trade Groups Defend Qualified Health Claims Following Critical GAO Report

This article was originally published in The Tan Sheet

Executive Summary

Dietary supplement industry stakeholders are defending the use of qualified health claims, which came under fire in a Government Accountability Office report on shortcomings in FDA's food labeling enforcement

You may also be interested in...



Claims Emerge To Join “Natural” As Class Action Fodder

Claims a product is “natural,” health and prevention claims, “whole grain” and “made with” claims, all can put a firm at risk for a lawsuit, the Center for Science in the Public Interest warns. After climbing for five years in a row, class action lawsuits brought against food products dipped in 2013, but the decline may be short-lived.

Claims Emerge To Join “Natural” As Class Action Fodder

Claims a product is “natural,” health and prevention claims, “whole grain” and “made with” claims, all can put a firm at risk for a lawsuit, the Center for Science in the Public Interest warns. After climbing for five years in a row, class action lawsuits brought against food products dipped in 2013, but the decline may be short-lived.

FDA To Study Selenium Health Claim Consumer Perceptions

The agency plans to study whether label claim language for selenium misleads consumers on the benefits of the ingredient. Legal experts say with the proposed study, FDA seeks to influence possible regulations down the road and circumvent court rulings that have curbed the agency’s authority to limit supplement claims.

Related Content

Topics

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel